ICON plc
South County Business Park
Leopardstown
Dublin,
18
Ireland - Map
Phone: 353 1 291 2000
Fax: 353 1 291 2700
Web Site: http://www.iconclinical.com
| ICON plc, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in the United States, Ireland, and rest of Europe. It specializes in strategic development, management, and analysis of programs that support clinical development from compound selection to Phase I to IV clinical studies. The companys clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, patient safety monitoring, clinical data management, interactive voice response, medical reporting, patient registries, outcomes research, and health economics. Its clinical research services also comprise strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynamic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, medical imaging, and contract staffing. In addition, the company provides various laboratory services, including sample analysis, safety testing, microbiology, custom flow cytometry, and electronic transmission of test results. ICON plc was founded in 1990 and is headquartered in Dublin, Ireland. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. John Climax Ph.D., 57
Co-Founder and Exec. Chairman |
N/A
| N/A | Mr. Peter Gray , 55
Chief Exec. Officer, Director and Chairman of Exec. Committee |
N/A
| N/A | Dr. Ronan Lambe MSC, Ph.D., 70
Co-Founder, Exec. Officer and Outside Director |
$
40.00K | N/A | Mr. Ciaran Murray , 47
Chief Fin. Officer, Principal Accounting Officer and Member of Exec. Committee |
N/A
| N/A | Dr. Guy Dewil ,
Chief Operating Officer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.14% Nasdaq 
Profile
